Stock 603858 SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shandong Buchang Pharmaceuticals Co., Ltd.

Equities

603858

CNE100002FV6

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
16.43 CNY +0.12% Intraday chart for Shandong Buchang Pharmaceuticals Co., Ltd. +3.66% -3.41%
04-25 Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-25 Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 22,407 22,807 25,516 23,326 23,238 18,814
Enterprise Value (EV) 1 22,964 23,309 27,111 25,150 23,660 20,917
P/E ratio 11.9 x 11.8 x 13.7 x 18.1 x -14 x 59 x
Yield 4.91% 7.83% 2.28% 1.71% 4.57% -
Capitalization / Revenue 1.64 x 1.6 x 1.59 x 1.48 x 1.55 x 1.42 x
EV / Revenue 1.68 x 1.64 x 1.69 x 1.6 x 1.58 x 1.58 x
EV / EBITDA 11.3 x 9.32 x 10 x 12.2 x 11.3 x 11.6 x
EV / FCF 37.1 x 15.3 x 31.2 x 27.5 x 12.1 x -48.7 x
FCF Yield 2.69% 6.51% 3.21% 3.64% 8.26% -2.05%
Price to Book 1.62 x 1.67 x 1.86 x 1.62 x 1.88 x 1.62 x
Nbr of stocks (in thousands) 1,152,242 1,106,043 1,106,043 1,106,043 1,106,043 1,106,043
Reference price 2 19.45 20.62 23.07 21.09 21.01 17.01
Announcement Date 19-04-25 20-04-27 21-04-28 22-04-27 23-04-28 24-04-25
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 13,665 14,255 16,007 15,763 14,951 13,245
EBITDA 1 2,036 2,500 2,709 2,059 2,100 1,802
EBIT 1 1,823 2,276 2,287 1,741 1,776 1,225
Operating Margin 13.34% 15.96% 14.29% 11.04% 11.88% 9.25%
Earnings before Tax (EBT) 1 2,255 2,415 2,361 1,714 -1,387 394.6
Net income 1 1,888 1,946 1,861 1,289 -1,657 319
Net margin 13.82% 13.65% 11.63% 8.18% -11.08% 2.41%
EPS 2 1.639 1.744 1.682 1.166 -1.498 0.2884
Free Cash Flow 1 618.6 1,519 870 915.4 1,955 -429.3
FCF margin 4.53% 10.65% 5.44% 5.81% 13.08% -3.24%
FCF Conversion (EBITDA) 30.39% 60.74% 32.11% 44.46% 93.11% -
FCF Conversion (Net income) 32.76% 78.03% 46.75% 71% - -
Dividend per Share 2 0.9550 1.614 0.5260 0.3600 0.9600 -
Announcement Date 19-04-25 20-04-27 21-04-28 22-04-27 23-04-28 24-04-25
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 558 503 1,595 1,823 422 2,104
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.274 x 0.201 x 0.5887 x 0.8855 x 0.2009 x 1.167 x
Free Cash Flow 1 619 1,519 870 915 1,955 -429
ROE (net income / shareholders' equity) 14.1% 14.2% 13.4% 8.74% -12.9% 1.28%
ROA (Net income/ Total Assets) 5.81% 6.9% 6.49% 4.64% 4.83% 3.57%
Assets 1 32,510 28,191 28,689 27,772 -34,288 8,923
Book Value Per Share 2 12.00 12.30 12.40 13.00 11.20 10.50
Cash Flow per Share 2 1.480 1.650 1.330 1.100 1.940 0.6300
Capex 1 1,310 662 536 434 543 530
Capex / Sales 9.59% 4.64% 3.35% 2.75% 3.63% 4%
Announcement Date 19-04-25 20-04-27 21-04-28 22-04-27 23-04-28 24-04-25
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-3.41% 2.51B
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+39.33% 6.11B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-18.38% 4.35B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.17% 3.19B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+3.98% 3.15B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+48.74% 1.98B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-4.82% 1.74B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-1.24% 1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-8.96% 1.6B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+39.87% 1.45B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 603858 Stock
  4. Financials Shandong Buchang Pharmaceuticals Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW